Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Lentz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Gastrointestinal Cancer|May 30, 2024
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E MutationBenjamin E Ueberroth, Christopher H Lieu, Robert W Lentz
Current Treatment Options in Oncology|March 28, 2024
HER2-Positive Metastatic Colorectal CancerHannah R Robinson, Wells A Messersmith, Robert W Lentz
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Simulated atmospheric processing of iron oxyhydroxide minerals at low pH: roles of particle size and acid anion in iron dissolutionGayan Rubasinghege, Robert W Lentz, Michelle M Scherer, et al.
Molecular Cancer Therapeutics|April 14, 2021
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?Robert W Lentz, Meryl D Colton, Siddhartha S Mitra, et al.
JAMA Cardiology|May 2, 2019
The Diagnostic and Prognostic Value of Echocardiographic StrainArushi Singh, Woo Bin Voss, Robert W Lentz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 3, 2009
Nanorod dissolution quenched in the aggregated stateGayan Rubasinghege, Robert W Lentz, Heaweon Park, et al.
Current Oncology Reports|November 3, 2025
From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal CancerElliott J Yee, Martin D McCarter, Jon D Vogel, et al.
The Oncologist|June 19, 2025
Oligometastatic pancreatic cancer: current state of management and emerging therapiesAndrii Khomiak, Nicole B Balmaceda, Sumaya A Ghaffar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Cancer Research Communications|September 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic MicroenvironmentJesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Gastrointestinal Cancer|May 30, 2024
Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E MutationBenjamin E Ueberroth, Christopher H Lieu, Robert W Lentz
Current Treatment Options in Oncology|March 28, 2024
HER2-Positive Metastatic Colorectal CancerHannah R Robinson, Wells A Messersmith, Robert W Lentz
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Simulated atmospheric processing of iron oxyhydroxide minerals at low pH: roles of particle size and acid anion in iron dissolutionGayan Rubasinghege, Robert W Lentz, Michelle M Scherer, et al.
Molecular Cancer Therapeutics|April 14, 2021
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?Robert W Lentz, Meryl D Colton, Siddhartha S Mitra, et al.
JAMA Cardiology|May 2, 2019
The Diagnostic and Prognostic Value of Echocardiographic StrainArushi Singh, Woo Bin Voss, Robert W Lentz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 3, 2009
Nanorod dissolution quenched in the aggregated stateGayan Rubasinghege, Robert W Lentz, Heaweon Park, et al.
Current Oncology Reports|November 3, 2025
From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal CancerElliott J Yee, Martin D McCarter, Jon D Vogel, et al.
The Oncologist|June 19, 2025
Oligometastatic pancreatic cancer: current state of management and emerging therapiesAndrii Khomiak, Nicole B Balmaceda, Sumaya A Ghaffar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Cancer Research Communications|September 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic MicroenvironmentJesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif, et al.
Pageof 2